For tirzepatide, the average weight loss is 8.31 pounds in the first month, (not even a pound greater than semaglutide), 15.73 pounds over the first two months (almost three pounds more than semaglutide), 19.34 pounds over the first three months (a pound greater than semaglutide) and 26.40 pounds over the first four months (three pounds more than semaglutide)
However, in the end, if these changes are not made, true health benefits may not be realized, and the patient would need the medication indefinitely to manage their weight. But the promise is real
The starting dose of Wegovy is 0.25mg once a week
Moreover, the overall death rate from all causes was lower among those taking Wegovy, a rare finding in clinical trials for new treatments
Genetic testing and biomarker assessment may provide clinical context, but they should not replace medical evaluation